Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04415905
Other study ID # 4-2020-0061
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 22, 2020
Est. completion date March 2, 2022

Study information

Verified date May 2022
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Caudal block is commonly used for postoperative analgesia in paediatric patients. A higher volume (1.5 ml/kg) of local anaesthetic for caudal block has been reported to not only increase the level of cranial spread but also provide better quality and longer duration of analgesia in comparison with the conventional volume (1.0 ml/kg). However, caudal block with a high volume of local anaesthetic can increase intracranial pressure (ICP). Previous studies have shown that propofol anesthesia lowers ICP when compared with volatile anesthesia. Therefore, this study was designed to test if propofol can reduce the magnitude of ICP increase following caudal block when compared with a volatile anesthetic, sevoflurane. There is increasing evidence that optic nerve sheath diameter (ONSD) measured by ultrasonography correlates with degree of ICP and is able to detect intracranial hypertension. Therefore, ONSD will be measured as a surrogate of ICP.


Description:

Equal number of patients are randomly assigned to the P or S group. The participants in the P and S group are anesthetized with propofol and sevoflurane, respectively. Irrespective of assigned group, all participants receive caudal block with 1.5 ml/kg of 0.15% ropivacaine (up to 30 ml per individual participant). All anesthetic procedures except for main anesthetic agent are the same in all participants. ONSD is measured at the following time points: before (T0), immediately after (T1), and 10 min (T2) and 30 min(T3) after caudal block. Two measurements of each optic nerve sheath are acquired in each eye. The mean value of the four measurements is considered as the ONSD at each time point.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date March 2, 2022
Est. primary completion date March 2, 2022
Accepts healthy volunteers No
Gender All
Age group 3 Years to 5 Years
Eligibility Inclusion Criteria: - Among children undergoing urological surgery, patients, 36 to 72-months-old - Body weight less than 20 kg (The limit on body weight is set because the maximum volume of local anaesthetic for caudal block in children is restricted to 30 ml.) - Treatment plan for caudal block for analgesia, are enrolled. Exclusion Criteria: - Symptoms or signs of spinal anomalies or infection at the sacral region - Coagulopathy - Increased ICP - Ophthalmic diseases - History of increased ICP

Study Design


Related Conditions & MeSH terms

  • Caudal Block for Postoperative Analgesia

Intervention

Drug:
Propofol
The participants in the group P are anesthetized with propofol
Sevoflurane
The participants in the group S are anesthetized with sevoflurane.

Locations

Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary ONSD ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously. before (T0) caudal block.
Primary ONSD ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously. immediately after (T1) caudal block.
Primary ONSD ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously. 10 minutes (T2) after caudal block.
Primary ONSD ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously. 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : Heart rate (beats per minute) before (T0) caudal block.
Secondary The variables affecting ICP : Heart rate (beats per minute) immediately after (T1) caudal block.
Secondary The variables affecting ICP : Heart rate (beats per minute) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : Heart rate (beats per minute) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : Mean arterial pressure (mmHg) before (T0) caudal block.
Secondary The variables affecting ICP : Mean arterial pressure (mmHg) immediately after (T1) caudal block.
Secondary The variables affecting ICP : Mean arterial pressure (mmHg) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : Mean arterial pressure (mmHg) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : End-tidal carbon dioxide partial pressure (mmHg) before (T0) caudal block.
Secondary The variables affecting ICP : End-tidal carbon dioxide partial pressure (mmHg) immediately after (T1) caudal block.
Secondary The variables affecting ICP : End-tidal carbon dioxide partial pressure (mmHg) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : End-tidal carbon dioxide partial pressure (mmHg) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : End-tidal sevoflurane concentration (volume %) before (T0) caudal block.
Secondary The variables affecting ICP : End-tidal sevoflurane concentration (volume %) immediately after (T1) caudal block.
Secondary The variables affecting ICP : End-tidal sevoflurane concentration (volume %) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : End-tidal sevoflurane concentration (volume %) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : Estimated propofol effect-site concentration (µg/ml) before (T0) caudal block.
Secondary The variables affecting ICP : Estimated propofol effect-site concentration (µg/ml) immediately after (T1) caudal block.
Secondary The variables affecting ICP : Estimated propofol effect-site concentration (µg/ml) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : Estimated propofol effect-site concentration (µg/ml) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : Body temperature (?) before (T0) caudal block.
Secondary The variables affecting ICP : Body temperature (?) immediately after (T1) caudal block.
Secondary The variables affecting ICP : Body temperature (?) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : Body temperature (?) 30 minutes (T3) after caudal block.
Secondary The variables affecting ICP : Peak inspiratory pressure (mmHg) before (T0) caudal block.
Secondary The variables affecting ICP : Peak inspiratory pressure (mmHg) immediately after (T1) caudal block.
Secondary The variables affecting ICP : Peak inspiratory pressure (mmHg) 10 minutes (T2) after caudal block.
Secondary The variables affecting ICP : Peak inspiratory pressure (mmHg) 30 minutes (T3) after caudal block.